Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oligonucleotide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chlorination-coupling method for alpha nucleosides. Reduces purification steps, improves selectivity for antisense drug manufacturing.
Patent CN121248673A details (2S)-UNA monomer synthesis enabling 5-prime to 3-prime oligonucleotide assembly with enhanced stability and supply chain reliability.
Novel scalable route for antisense oligonucleotide intermediates ensuring high purity and cost reduction without preparative chromatography.
Novel one-pot synthesis method for high-purity nucleoside dimer phosphoramidites. Reduces steps and reagent costs for oligonucleotide manufacturing.